Sale!

RSPH4A Gene Primary Ciliary Dyskinesia Type 11 NGS Genetic DNA Test

Original price was: ₦ 560,000.Current price is: ₦ 400,000.

-29%

The RSPH4A Gene Primary Ciliary Dyskinesia Type 11 NGS Genetic DNA Test is essential for diagnosing primary ciliary dyskinesia (PCD), a genetic disorder affecting the respiratory system. Priced at 400000 NGN, this test utilizes next-generation sequencing (NGS) technology to analyze the RSPH4A gene, which is crucial in the function of cilia. Early diagnosis can significantly improve management strategies and patient outcomes. Book your test today!

Book your test online and get free home sample collection

  • 100% Accurate Test Results
  • Get Tested at Nigeria No1 Genetic DNA Lab
  • Customer support Call 08077798758
Guaranteed Safe Checkout

RSPH4A Gene Primary Ciliary Dyskinesia Type 11 NGS Genetic DNA Test

Introduction

The RSPH4A Gene Primary Ciliary Dyskinesia Type 11 NGS Genetic DNA Test is a groundbreaking diagnostic tool that enables healthcare providers to identify mutations in the RSPH4A gene, which is associated with primary ciliary dyskinesia (PCD). PCD is a genetic disorder characterized by the abnormal function of cilia, leading to chronic respiratory issues and other complications. Understanding the genetic basis of PCD is crucial for early diagnosis and effective management.

What the Test Measures

This test specifically analyzes the RSPH4A gene using next-generation sequencing (NGS) technology. It detects mutations that may lead to the dysfunction of cilia, which play a vital role in clearing mucus and pathogens from the respiratory tract.

Who Should Consider This Test

Individuals experiencing chronic respiratory infections, unexplained infertility, or have a family history of PCD should consider this test. Symptoms may include:

  • Chronic cough
  • Frequent ear infections
  • Sinusitis
  • Bronchiectasis

Consulting an ENT doctor or a genetic specialist can help determine if this test is appropriate based on clinical history and symptoms.

Benefits of Taking the Test

  • Early diagnosis of PCD can lead to better management strategies.
  • Understanding genetic predispositions can inform treatment options.
  • Provides valuable information for family planning and genetic counseling.

Understanding Your Results

Results from the RSPH4A Gene test can help determine the presence of mutations associated with PCD. A healthcare provider will guide you through the interpretation of results, helping you understand potential implications for your health and treatment options.

Test Pricing

Discount Price Regular Price
400,000 NGN 560,000 NGN

Book Your Test Today!

Don’t wait to take control of your health. To schedule the RSPH4A Gene Primary Ciliary Dyskinesia Type 11 NGS Genetic DNA Test, please call or WhatsApp us at +2348077798758. Our team is ready to assist you with the booking process and any questions you may have.

Additional Information

Turnaround time for results is approximately 3 to 4 weeks. The test requires a sample of blood or extracted DNA, or one drop of blood on an FTA card. Prior to testing, a genetic counseling session is recommended to discuss clinical history and family pedigree related to PCD.

Take the first step towards understanding your health with the RSPH4A Gene Primary Ciliary Dyskinesia Type 11 NGS Genetic DNA Test at DNA Labs Nigeria!